IFNG and cancer: PD-L1, upregulated by IFN gamma (IFNγ) and oncogenic signalling in cancer cells, plays a crucial role in inhibiting the killing activity of immune cells targeting cancer cells (Garcia-Diaz et al, 2017; Yamaguchi et al, 2022).